Skip to main content
. 2019 May 17;10(4):1189–1204. doi: 10.1007/s13300-019-0629-z

Table 1.

Choice of basal insulin and GLAs in special populations

Population Special concern Choice of BI Titration Additional GLAs
Fasting/Ramadan Hypoglycemia Gla-100/Gla-300/degludec Slow DPP4i/TZD/glipizide/repaglinide
Pregnancy Safety NPH/Detemir/Glargine Early titration until target Metformin
Elderly Hypoglycemia Gla-100/Gla-300/degludec Slow/weekly DPP4i/metformin/SU

BI basal insulin, DPP4i dipeptidyl peptidase-4 inhibitor, NPH neutral protamine Hagedorn, GLA oral glucose-lowering agents, TZD thiazolidinediones, SU sulfonylureas